CureVac Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . CureVac NV
CVAC Stock  USD 4.66  0.00  0.00%   
CureVac NV's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing CureVac NV's valuation are provided below:
Gross Profit
66 M
Profit Margin
1.8211
Market Capitalization
1 B
Enterprise Value Revenue
7.2313
Revenue
70.7 M
We have found one hundred twenty available fundamental signals for CureVac NV, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of CureVac NV's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. As of February 10, 2026, Market Cap is expected to decline to about 807.2 M. In addition to that, Enterprise Value is expected to decline to about 323.5 M

CureVac NV Total Revenue

646.23 Million

Check CureVac NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CureVac NV's main balance sheet or income statement drivers, such as Tax Provision of 34.6 M, Net Interest Income of 14.9 M or Interest Income of 14.9 M, as well as many indicators such as Price To Sales Ratio of 1.51, Dividend Yield of 0.0 or PTB Ratio of 1.16. CureVac financial statements analysis is a perfect complement when working with CureVac NV Valuation or Volatility modules.
  
Build AI portfolio with CureVac Stock
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

CureVac NV Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets845 M923.3 M479.5 M
Slightly volatile
Short and Long Term Debt Total41 M44.8 M20.4 M
Slightly volatile
Other Current Liabilities65.7 M36.2 M36.8 M
Slightly volatile
Total Current Liabilities79 M83.2 M86.1 M
Slightly volatile
Other Liabilities198.2 M99.6 M106 M
Slightly volatile
Property Plant And Equipment Net185.8 M281.3 M118.4 M
Slightly volatile
Current Deferred Revenue56.5 M51.3 M29.8 M
Slightly volatile
Accounts Payable18.9 M19.9 M23.5 M
Slightly volatile
Cash560.4 M554 M285.4 M
Slightly volatile
Non Current Assets Total208.8 M317.9 M133.9 M
Slightly volatile
Non Currrent Assets Other1.3 M1.7 M657.8 K
Slightly volatile
Other Assets8559004.6 M
Slightly volatile
Cash And Short Term Investments569.6 M558.2 M308.1 M
Slightly volatile
Net Receivables25.3 M37.8 M16.4 M
Slightly volatile
Common Stock Total Equity26.1 M24.9 M9.8 M
Slightly volatile
Common Stock Shares Outstanding206.8 M259.1 M187.6 M
Slightly volatile
Short Term Investments3.1 M3.3 M22.3 M
Slightly volatile
Liabilities And Stockholders Equity845 M923.3 M479.5 M
Slightly volatile
Non Current Liabilities Total29 M30.5 M102.8 M
Very volatile
Inventory591 K622.1 K9.1 M
Slightly volatile
Other Current Assets16.3 M8.7 M8.8 M
Slightly volatile
Total Liabilities90.8 M95.6 M186.9 M
Slightly volatile
Deferred Long Term Liabilities258.2 K271.8 K628.9 K
Slightly volatile
Net Invested Capital503 M801.1 M280.1 M
Slightly volatile
Property Plant And Equipment Gross210.3 M371.7 M132 M
Slightly volatile
Total Current Assets636.3 M605.4 M345.6 M
Slightly volatile
Accumulated Other Comprehensive Income1.6 B2.4 B1 B
Slightly volatile
Capital Stock19.3 M31 M10.5 M
Slightly volatile
Non Current Liabilities Other16.2 K17.1 K525.5 K
Slightly volatile
Net Working Capital467.1 M522.2 M254.2 M
Slightly volatile
Short Term Debt3.8 M6.1 M2.1 M
Slightly volatile
Intangible Assets13.7 M14.6 M9.7 M
Slightly volatile
Common Stock19.3 M31 M10.5 M
Slightly volatile
Property Plant Equipment242 M230.5 M105.9 M
Slightly volatile
Long Term Debt52 M58.5 M63.9 M
Slightly volatile

CureVac NV Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income14.9 M14.2 M5.2 M
Slightly volatile
Depreciation And Amortization19.9 M21.6 M11.7 M
Slightly volatile
Selling General Administrative67.5 M80.1 M43.6 M
Slightly volatile
Selling And Marketing Expenses5.4 M5.1 M1.8 M
Slightly volatile
Total Revenue646.2 M615.5 M129.6 M
Slightly volatile
Other Operating Expenses295.5 M411.1 M192.5 M
Slightly volatile
Research Development211.5 M176 M121.6 M
Slightly volatile
Cost Of Revenue111.9 M121.7 M64 M
Slightly volatile
Total Operating Expenses185.8 M289.4 M129.5 M
Slightly volatile
Reconciled Depreciation15.3 M21.6 M9.7 M
Slightly volatile

CureVac NV Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow500.3 M462.8 M290.8 M
Slightly volatile
Depreciation16.2 M21.6 M10.1 M
Slightly volatile
Capital Expenditures20.2 M21.2 M31.1 M
Slightly volatile
End Period Cash Flow560.4 M554 M285.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.511.59400
Slightly volatile
Days Sales Outstanding24.5225.81159
Slightly volatile
Capex To Depreciation1.071.133.4598
Slightly volatile
EV To Sales0.60.64396
Slightly volatile
Inventory Turnover18517637.2394
Slightly volatile
Days Of Inventory On Hand2.042.1571.4039
Very volatile
Payables Turnover5.795.512.8471
Slightly volatile
Sales General And Administrative To Revenue0.140.151.2717
Slightly volatile
Research And Ddevelopement To Revenue0.310.332.7008
Slightly volatile
Capex To Revenue0.03770.03960.9252
Slightly volatile
Cash Per Share2.461.951.6907
Slightly volatile
Days Payables Outstanding65.0868.51168
Slightly volatile
Intangibles To Total Assets0.03430.0360.0402
Slightly volatile
Current Ratio6.886.553.5686
Slightly volatile
Receivables Turnover15.3714.645.9875
Slightly volatile
Graham Number5.696.46.981
Slightly volatile
Capex Per Share0.07030.0740.1667
Slightly volatile
Revenue Per Share2.252.150.533
Slightly volatile
Interest Debt Per Share0.260.20.1254
Slightly volatile
Debt To Assets0.0530.05580.0539
Pretty Stable
Operating Cycle26.5527.95230
Slightly volatile
Days Of Payables Outstanding65.0868.51168
Slightly volatile
Ebt Per Ebit0.810.970.9791
Pretty Stable
Long Term Debt To Capitalization2.342.632.8747
Slightly volatile
Total Debt To Capitalization0.05790.06090.1529
Very volatile
Quick Ratio6.876.543.4689
Slightly volatile
Net Income Per E B T1.080.980.9949
Pretty Stable
Cash Ratio6.295.992.342
Slightly volatile
Days Of Inventory Outstanding2.042.1571.4039
Very volatile
Days Of Sales Outstanding24.5225.81159
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.220.941.1484
Slightly volatile
Fixed Asset Turnover2.071.970.6169
Slightly volatile
Debt Ratio0.0530.05580.0539
Pretty Stable
Price Sales Ratio1.511.59400
Slightly volatile
Asset Turnover0.630.60.1894
Slightly volatile

CureVac NV Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap807.2 M849.7 M6.2 B
Slightly volatile
Enterprise Value323.5 M340.5 M5.9 B
Slightly volatile

CureVac Fundamental Market Drivers

Forward Price Earnings5.2356
Cash And Short Term Investments485.4 M

CureVac Upcoming Events

23rd of April 2024
Upcoming Quarterly Report
View
4th of June 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
23rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About CureVac NV Financial Statements

CureVac NV stakeholders use historical fundamental indicators, such as CureVac NV's revenue or net income, to determine how well the company is positioned to perform in the future. Although CureVac NV investors may analyze each financial statement separately, they are all interrelated. For example, changes in CureVac NV's assets and liabilities are reflected in the revenues and expenses on CureVac NV's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CureVac NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue51.3 M56.5 M
Total Revenue615.5 M646.2 M
Cost Of Revenue121.7 M111.9 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.15  0.14 
Research And Ddevelopement To Revenue 0.33  0.31 
Capex To Revenue 0.04  0.04 
Revenue Per Share 2.15  2.25 
Ebit Per Revenue 0.30  0.31 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:
How To Invest In CureVac
Details
Is CureVac Stock a good investment?
Details
What is CureVac NV's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Will Biotechnology sector continue expanding? Could CureVac diversify its offerings? Factors like these will boost the valuation of CureVac NV. Projected growth potential of CureVac fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CureVac NV data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.24
Earnings Share
0.67
Revenue Per Share
0.44
Quarterly Revenue Growth
(0.89)
Return On Assets
0.2377
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between CureVac NV's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CureVac NV should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CureVac NV's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY